@article{5f97e7e194a34d5b9eb27e2836f1b026,
title = "The Importance of a Cause-Based Protocol to Approach Cancer-Related Nausea and Vomiting - Reply",
author = "Loprinzi, {Charles L.} and Le-Rademacher, {Jennifer G.} and Navari, {Rudolph M.}",
note = "Funding Information: Conflict of Interest Disclosures: Dr Loprinzi reported receiving grants from the National Cancer Institute and personal fees from PledPharma, Disarm Therapeutics, Asahi Kasei, Metys Pharmaceuticals, NKMax, Novartis, OnQuality Pharmaceuticals, and Mitsubishi Tanabe Pharma. Dr Le-Rademacher reported receiving grants from Mayo Clinic during the conduct of the study. No other disclosures were reported. Funding Information: Funding/Support: This work was supported by Capital{\textquoteright}s Funds for Health Improvement and Research (No. 2018-2-4065), National Natural Science Foundation of China (No. 81873396), and China-Japan Friendship Hospital.",
year = "2020",
doi = "10.1001/jamaoncol.2020.3706",
language = "English (US)",
volume = "6",
pages = "1812--1813",
journal = "JAMA Oncology",
issn = "2374-2437",
publisher = "American Medical Association",
number = "11",
}